Immunotherapy, also known as allergen-specific immunotherapy or desensitization, involves gradually increasing doses of specific allergens to induce immune tolerance and modify the allergic response. The therapy aims to alleviate symptoms, reduce medication usage, and potentially modify the underlying disease process. Several studies have investigated the effects of immunotherapy on asthma patients, providing insights into its clinical efficacy and safety. Research studies have shown positive outcomes of immunotherapy in bronchial asthma. A randomized controlled trial demonstrated significant improvements in asthma symptoms, decreased medication use, and reduced airway hyperresponsiveness in patients who received subcutaneous immunotherapy compared to the placebo group. Another study focusing on children showed improvements in lung function and reduced asthma exacerbations with sublingual immunotherapy. Long-term effects of immunotherapy were explored in a prospective cohort study on adults with moderate-to-severe persistent allergic asthma. The study found sustained improvements in asthma control, reduced rescue medication use, and a de